Literature DB >> 14992272

Taurine and skeletal muscle disorders.

Diana Conte Camerino1, Domenico Tricarico, Sabata Pierno, Jean-François Desaphy, Antonella Liantonio, Michael Pusch, Rosa Burdi, Claudia Camerino, Bodvael Fraysse, Annamaria De Luca.   

Abstract

Taurine is abundantly present in skeletal muscle. We give evidence that this amino acid exerts both short-term and long-term actions in the control of ion channel function and calcium homeostasis in striated fibers. Short-term actions can be estimated as the ability of this amino acid to acutely modulate both ion channel gating and the function of the structures involved in calcium handling. Long-term effects can be disclosed in situations of tissue taurine depletion and are likely related to the ability of the intracellular taurine to control transducing pathways as well as homeostatic and osmotic equilibrium in the tissue. The two activities are strictly linked because the intracellular level of taurine modulates the sensitivity of skeletal muscle to the exogenous application of taurine. Myopathies in which ion channels are directly or indirectly involved, as well as inherited or acquired pathologies characterized by metabolic alterations and change in calcium homeostasis, are often correlated with change in muscle taurine concentration and consequently with an enhanced therapeutic activity of this amino acid. We discuss both in vivo and in vitro evidence that taurine, through its ability to control sarcolemmal excitability and muscle contractility, can prove beneficial effects in many muscle dysfunctions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14992272     DOI: 10.1023/b:nere.0000010442.89826.9c

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  55 in total

Review 1.  Taurine and skeletal muscle ion channels.

Authors:  A De Luca; S Pierno; D Tricarico; J F Desaphy; A Liantonio; M Barbieri; C Camerino; L Montanari; D C Camerino
Journal:  Adv Exp Med Biol       Date:  2000       Impact factor: 2.622

2.  Free amino acids in muscle: effect of muscle fiber population and denervation.

Authors:  J Turinsky; C L Long
Journal:  Am J Physiol       Date:  1990-03

3.  Molecular determinants of mexiletine structure for potent and use-dependent block of skeletal muscle sodium channels.

Authors:  A De Luca; F Natuzzi; J F Desaphy; G Loni; G Lentini; C Franchini; V Tortorella; D C Camerino
Journal:  Mol Pharmacol       Date:  2000-02       Impact factor: 4.436

4.  Pharmacological interventions for the changes of chloride channel conductance of aging rat skeletal muscle.

Authors:  A De Luca; S Pierno; D Conte Camerino
Journal:  Ann N Y Acad Sci       Date:  1994-06-30       Impact factor: 5.691

5.  The treatment of myotonia: evaluation of chronic oral taurine therapy.

Authors:  L Durelli; R Mutani; F Fassio
Journal:  Neurology       Date:  1983-05       Impact factor: 9.910

Review 6.  Role of osmoregulation in the actions of taurine.

Authors:  S Schaffer; K Takahashi; J Azuma
Journal:  Amino Acids       Date:  2000       Impact factor: 3.520

Review 7.  Molecular pathophysiology and targeted therapeutics for muscular dystrophy.

Authors:  E P Hoffman; D Dressman
Journal:  Trends Pharmacol Sci       Date:  2001-09       Impact factor: 14.819

8.  Taurine depletion, a novel mechanism for cardioprotection from regional ischemia.

Authors:  S N Allo; L Bagby; S W Schaffer
Journal:  Am J Physiol       Date:  1997-10

9.  Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1.

Authors:  Annamaria De Luca; Sabata Pierno; Antonella Liantonio; Michela Cetrone; Claudia Camerino; Bodvael Fraysse; Massimo Mirabella; Serenella Servidei; Urs T Rüegg; Diana Conte Camerino
Journal:  J Pharmacol Exp Ther       Date:  2003-01       Impact factor: 4.030

10.  Effect of taurine depletion on excitation-contraction coupling and Cl- conductance of rat skeletal muscle.

Authors:  A De Luca; S Pierno; D C Camerino
Journal:  Eur J Pharmacol       Date:  1996-01-25       Impact factor: 4.432

View more
  22 in total

1.  Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.

Authors:  Jessica R Terrill; Gavin J Pinniger; Jamie A Graves; Miranda D Grounds; Peter G Arthur
Journal:  J Physiol       Date:  2016-01-18       Impact factor: 5.182

2.  Early metabolic changes measured by 1H MRS in healthy and dystrophic muscle after injury.

Authors:  Su Xu; Stephen J P Pratt; Espen E Spangenburg; Richard M Lovering
Journal:  J Appl Physiol (1985)       Date:  2012-06-28

Review 3.  Neurogenic muscle cramps.

Authors:  Hans D Katzberg
Journal:  J Neurol       Date:  2015-02-12       Impact factor: 4.849

4.  Taurine supplementation increases skeletal muscle force production and protects muscle function during and after high-frequency in vitro stimulation.

Authors:  Craig A Goodman; Deanna Horvath; Christos Stathis; Trevor Mori; Kevin Croft; Robyn M Murphy; Alan Hayes
Journal:  J Appl Physiol (1985)       Date:  2009-05-07

5.  Abnormalities in brain structure and biochemistry associated with mdx mice measured by in vivo MRI and high resolution localized (1)H MRS.

Authors:  Su Xu; Da Shi; Stephen J P Pratt; Wenjun Zhu; Andrew Marshall; Richard M Lovering
Journal:  Neuromuscul Disord       Date:  2015-07-10       Impact factor: 4.296

6.  Niflumic acid inhibits chloride conductance of rat skeletal muscle by directly inhibiting the CLC-1 channel and by increasing intracellular calcium.

Authors:  A Liantonio; V Giannuzzi; A Picollo; E Babini; M Pusch; D Conte Camerino
Journal:  Br J Pharmacol       Date:  2006-11-27       Impact factor: 8.739

7.  Hyperreflexia and enhanced ripple oscillations in the taurine-deficient mice.

Authors:  Narmin Mekawy; Meriem Bendaoud; Yassine Yachou; Abdeslem El Idrissi
Journal:  Amino Acids       Date:  2021-04-20       Impact factor: 3.520

Review 8.  Cardiac and skeletal muscle abnormality in taurine transporter-knockout mice.

Authors:  Takashi Ito; Shohei Oishi; Mika Takai; Yasushi Kimura; Yoriko Uozumi; Yasushi Fujio; Stephen W Schaffer; Junichi Azuma
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

9.  The different impact of a high fat diet on dystrophic mdx and control C57Bl/10 mice.

Authors:  Hannah G Radley-Crabb; Marta L Fiorotto; Miranda D Grounds
Journal:  PLoS Curr       Date:  2011-11-15

Review 10.  Ion channel pharmacology.

Authors:  Diana Conte Camerino; Domenico Tricarico; Jean-François Desaphy
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.